Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida. more
Time Frame | SBFM | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.09% | -2.12% | -2.22% |
1-Month Return | 27.52% | -3.42% | 0.07% |
3-Month Return | -12.03% | -11.13% | 3.71% |
6-Month Return | -59.71% | -5.74% | 8.04% |
1-Year Return | -99.45% | 3.97% | 26.32% |
3-Year Return | -99.99% | 1.05% | 29.42% |
5-Year Return | -99.91% | 34.37% | 83.36% |
10-Year Return | -100% | 97.88% | 185.56% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 21.12K | 71.41K | 228.43K | 4.35M | 24.09M | [{"date":"2019-12-31","value":0.09,"profit":true},{"date":"2020-12-31","value":0.3,"profit":true},{"date":"2021-12-31","value":0.95,"profit":true},{"date":"2022-12-31","value":18.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 11.05K | 25.85K | 117.83K | 2.65M | 15.75M | [{"date":"2019-12-31","value":0.07,"profit":true},{"date":"2020-12-31","value":0.16,"profit":true},{"date":"2021-12-31","value":0.75,"profit":true},{"date":"2022-12-31","value":16.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 10.07K | 45.56K | 110.60K | 1.70M | 8.34M | [{"date":"2019-12-31","value":0.12,"profit":true},{"date":"2020-12-31","value":0.55,"profit":true},{"date":"2021-12-31","value":1.33,"profit":true},{"date":"2022-12-31","value":20.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 47.68% | 63.80% | 48.42% | 39.04% | 34.61% | [{"date":"2019-12-31","value":74.73,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":75.88,"profit":true},{"date":"2022-12-31","value":61.19,"profit":true},{"date":"2023-12-31","value":54.25,"profit":true}] |
Operating Expenses | 651.71K | 622.44K | 2.55M | 10.37M | 13.12M | [{"date":"2019-12-31","value":4.97,"profit":true},{"date":"2020-12-31","value":4.74,"profit":true},{"date":"2021-12-31","value":19.43,"profit":true},{"date":"2022-12-31","value":79.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (641.64K) | (576.87K) | (2.44M) | (8.67M) | (4.79M) | [{"date":"2019-12-31","value":-64163600,"profit":false},{"date":"2020-12-31","value":-57687400,"profit":false},{"date":"2021-12-31","value":-244013400,"profit":false},{"date":"2022-12-31","value":-867403100,"profit":false},{"date":"2023-12-31","value":-478529900,"profit":false}] |
Total Non-Operating Income/Expense | (552.32K) | (2.38M) | (10.33M) | 968.85K | 1.28M | [{"date":"2019-12-31","value":-43.26,"profit":false},{"date":"2020-12-31","value":-186.05,"profit":false},{"date":"2021-12-31","value":-808.73,"profit":false},{"date":"2022-12-31","value":75.89,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (1.08M) | (2.78M) | (12.44M) | (26.51M) | (4.11M) | [{"date":"2019-12-31","value":-107805400,"profit":false},{"date":"2020-12-31","value":-278409100,"profit":false},{"date":"2021-12-31","value":-1243644700,"profit":false},{"date":"2022-12-31","value":-2651113600,"profit":false},{"date":"2023-12-31","value":-411087700,"profit":false}] |
Income Taxes | 383.39K | (1.89M) | 328.82K | 233.30K | 395.17K | [{"date":"2019-12-31","value":97.02,"profit":true},{"date":"2020-12-31","value":-477.37,"profit":false},{"date":"2021-12-31","value":83.21,"profit":true},{"date":"2022-12-31","value":59.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (1.46M) | (897.68K) | (12.77M) | (26.74M) | (4.51M) | [{"date":"2019-12-31","value":-146144000,"profit":false},{"date":"2020-12-31","value":-89768300,"profit":false},{"date":"2021-12-31","value":-1276526500,"profit":false},{"date":"2022-12-31","value":-2674444000,"profit":false},{"date":"2023-12-31","value":-450604300,"profit":false}] |
Income From Continuous Operations | (1.08M) | (2.78M) | (12.44M) | (26.74M) | (26.77M) | [{"date":"2019-12-31","value":-107805400,"profit":false},{"date":"2020-12-31","value":-278409100,"profit":false},{"date":"2021-12-31","value":-1243644700,"profit":false},{"date":"2022-12-31","value":-2674444000,"profit":false},{"date":"2023-12-31","value":-2676833500,"profit":false}] |
Income From Discontinued Operations | (582.24K) | - | - | - | - | [{"date":"2019-12-31","value":-58223700,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.46M) | (897.68K) | (12.77M) | (26.74M) | (4.51M) | [{"date":"2019-12-31","value":-146144000,"profit":false},{"date":"2020-12-31","value":-89768300,"profit":false},{"date":"2021-12-31","value":-1276526500,"profit":false},{"date":"2022-12-31","value":-2674444000,"profit":false},{"date":"2023-12-31","value":-450604400,"profit":false}] |
EPS (Diluted) | (0.08) | (0.04) | 0.23 | (2.08K) | (6.11) | [{"date":"2019-12-31","value":-36.83,"profit":false},{"date":"2020-12-31","value":-16.26,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-905391.09,"profit":false},{"date":"2023-12-31","value":-2656.52,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SBFM | |
---|---|
Cash Ratio | 2.70 |
Current Ratio | 5.74 |
Quick Ratio | 3.57 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SBFM | |
---|---|
ROA (LTM) | -10.75% |
ROE (LTM) | -17.98% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SBFM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.17 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.83 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SBFM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.17 |
P/B | 0.22 |
Price/FCF | NM |
EV/R | 39.48 |
EV/Ebitda | NM |
PEG | NM |
Sunshine Biopharma Inc (SBFM) share price today is $2.751
Yes, Indians can buy shares of Sunshine Biopharma Inc (SBFM) on Vested. To buy Sunshine Biopharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SBFM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Sunshine Biopharma Inc (SBFM) via the Vested app. You can start investing in Sunshine Biopharma Inc (SBFM) with a minimum investment of $1.
You can invest in shares of Sunshine Biopharma Inc (SBFM) via Vested in three simple steps:
The 52-week high price of Sunshine Biopharma Inc (SBFM) is $608. The 52-week low price of Sunshine Biopharma Inc (SBFM) is $2.11.
The price-to-earnings (P/E) ratio of Sunshine Biopharma Inc (SBFM) is
The price-to-book (P/B) ratio of Sunshine Biopharma Inc (SBFM) is 0.22
The dividend yield of Sunshine Biopharma Inc (SBFM) is 0.00%
The market capitalization of Sunshine Biopharma Inc (SBFM) is $5.56M
The stock symbol (or ticker) of Sunshine Biopharma Inc is SBFM